INIS
Radnostix, Inc.
OTC Markets OTCQBUSDEQUITY
Healthcare
DELAYED
Last price
0.07
▲ 0.01 (16.67%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.07
Prev close
0.06
Day high
0.06
Day low
0.06
Volume
25.60K
Market cap
$37.04M
P/E (TTM)
—
52W range
0.05 – 0.11
Day trading desk
Gap from prior close
+16.67%
Prior close 0.06
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
0.07 – 0.07
Position in range
—
—
ATR (14D)
0.01
12.24% of price
Prior day high
0.06
PDH
Prior day low
0.05
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 45.22K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
+16.67%
+12.9%
3M
-12.50%
-15.6%
6M
-22.22%
-33.3%
YTD
+16.67%
+4.4%
1Y
-22.22%
-42.2%
3Y
-12.50%
-86.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on INIS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
388.74M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 10, 25 | ATCHER ROBERT Director |
STOCK | 250.00K | $0 | Direct |
| May 22, 25 | BAGERDJIAN SHAHE Chief Executive Officer |
BUY | 140.00K | $7.00K | Direct |
| Mar 6, 25 | BAGERDJIAN SHAHE Chief Executive Officer |
BUY | 177.00K | $8.85K | Direct |
| Nov 22, 24 | COX W MATTHEW Chief Financial Officer |
BUY | 90.00K | $3.00K | Direct |
| Nov 20, 24 | BAGERDJIAN SHAHE Chief Executive Officer |
BUY | 100.00K | $4.00K | Direct |
| Nov 14, 24 | GROSSO CHRISTOPHER G. Director |
BUY | 401.12K | $12.03K | Indirect |
| Sep 18, 24 | GROSSO CHRISTOPHER G. Director |
BUY | 800.00K | $24.00K | |
| Sep 13, 24 | BAGERDJIAN SHAHE Chief Executive Officer |
STOCK | 350.00K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ATCHER ROBERT |
Director | 1.00M | Stock Award(Grant) |
BAGERDJIAN SHAHE |
Chief Executive Officer | 9.03M | Purchase |
COX W MATTHEW |
Chief Financial Officer | 897.74K | Purchase |
GROSSO CHRISTOPHER G. |
Director | — | Purchase |
Fundamentals
Market cap$37.04M
Enterprise value$43.36M
Revenue (TTM)$11.23M
Gross profit$6.04M
EBITDA$-2.40M
Net income$-2.86M
EPS (TTM)$0.00
Free cash flow$-142.16K
Total cash$1.20M
Total debt$9.21M
Book value / share$0.00
Shares outstanding529.15M
Float332.30M
Short % of float—
Dividend yield—
Beta (5Y)1.25
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio5.59
Price / sales—
Price / book17.50
EV / revenue3.86
EV / EBITDA-18.03
Gross margin53.79%
Operating margin-31.22%
Profit margin-25.52%
Return on equity-93.04%
Return on assets-10.62%
Debt / equity486.77
Current ratio0.84
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $13.07M | $13.90M | $12.27M | $11.18M | -6.0% |
| Operating revenue | $13.07M | $13.90M | $12.27M | $11.18M | -6.0% |
| Cost of revenue | $5.37M | $5.25M | $4.89M | $4.89M | +2.2% |
| Gross profit | $7.70M | $8.65M | $7.38M | $6.29M | -10.9% |
| Research & development | $435.84K | $610.74K | $577.35K | $533.72K | -28.6% |
| Selling, general & admin | $8.22M | $8.03M | $7.58M | $6.96M | +2.4% |
| Total operating expense | $8.66M | $8.64M | $8.16M | $7.49M | +0.2% |
| Operating income | -$956.19K | $6.90K | -$776.30K | -$1.20M | -13,955.8% |
| Net interest income | -$262.65K | -$206.29K | -$252.89K | -$604.44K | -27.3% |
| Pre-tax income | -$908.00K | $8.57K | -$869.02K | $303.24K | -10,690.2% |
| Net income | -$908.00K | $8.57K | -$869.02K | $303.24K | -10,690.2% |
| Net income to common | -$908.00K | $8.57K | -$869.02K | $303.24K | -10,690.2% |
| Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | — |
| EBIT | -$568.72K | $337.25K | -$537.24K | $917.18K | -268.6% |
| EBITDA | -$166.28K | $738.32K | -$187.14K | $1.29M | -122.5% |
| Basic shares | 526.80M | 522.29M | 517.78M | 510.79M | +0.9% |
| Diluted shares | 526.80M | 522.29M | 517.78M | 510.79M | +0.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.70M | $1.95M | $2.69M | $2.38M | -12.9% |
| Cash & short-term investments | $1.70M | $1.95M | $2.69M | $2.38M | -12.9% |
| Accounts receivable | $1.42M | $1.52M | $1.47M | $1.60M | -6.8% |
| Inventory | $875.45K | $820.89K | $927.11K | $744.79K | +6.6% |
| Total current assets | $4.63M | $4.99M | $5.76M | $5.74M | -7.2% |
| Property, plant & equipment | $7.13M | $5.99M | $5.34M | $4.58M | +19.1% |
| Goodwill & intangibles | $4.59M | $4.76M | $4.92M | $5.09M | -3.5% |
| Total assets | $17.84M | $17.16M | $16.91M | $16.24M | +3.9% |
| Total current liabilities | $3.97M | $3.33M | $3.27M | $3.51M | +19.4% |
| Current debt | $162.72K | $308.40K | $155.73K | $643.35K | -47.2% |
| Long-term debt | $1.77M | $1.90M | $1.89M | $1.03M | -6.8% |
| Total debt | $4.84M | $4.30M | $4.28M | $4.05M | +12.5% |
| Total liabilities | $14.14M | $12.81M | $12.87M | $11.90M | +10.4% |
| Retained earnings | -$128.23M | -$127.32M | -$127.33M | -$126.46M | -0.7% |
| Shareholder equity | $3.69M | $4.35M | $4.04M | $4.34M | -15.1% |
| Working capital | $651.40K | $1.66M | $2.48M | $2.23M | -60.7% |
| Net tangible assets | -$900.18K | -$410.81K | -$886.09K | -$745.07K | -119.1% |
| Shares issued | 528.21M | 523.55M | 519.79M | 514.89M | +0.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$908.00K | $8.57K | -$869.02K | $303.24K | -10,690.2% |
| Depreciation & amortisation | $402.44K | $401.07K | $350.09K | $371.67K | +0.3% |
| Stock-based compensation | $117.82K | $199.42K | $464.04K | $352.46K | -40.9% |
| Change in working capital | $917.65K | -$22.63K | $588.82K | -$1.05M | +4,154.5% |
| Operating cash flow | $620.16K | $638.78K | $582.59K | -$1.50M | -2.9% |
| Capital expenditure | -$534.15K | -$721.22K | -$149.06K | -$120.01K | +25.9% |
| Investing cash flow | -$534.15K | -$685.22K | -$149.06K | $3.88M | +22.0% |
| Financing cash flow | -$275.86K | -$145.23K | -$80.50K | -$472.00K | -89.9% |
| Free cash flow | $86.01K | -$82.43K | $433.53K | -$1.62M | +204.3% |
| End cash position | $3.19M | $3.38M | $3.57M | $3.22M | -5.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.38M | $2.90M | $3.28M | $3.66M | $3.24M | -17.9% |
| Operating revenue | $2.38M | $2.90M | $3.28M | $3.66M | $3.24M | -17.9% |
| Cost of revenue | $1.23M | $1.31M | $1.34M | $1.51M | $1.21M | -6.2% |
| Gross profit | $1.15M | $1.59M | $1.94M | $2.14M | $2.03M | -27.6% |
| Research & development | $149.13K | $87.06K | $139.41K | $102.66K | $106.70K | +71.3% |
| Selling, general & admin | $2.31M | $2.08M | $1.98M | $2.17M | $1.99M | +11.3% |
| Total operating expense | $2.46M | $2.16M | $2.12M | $2.28M | $2.10M | +13.7% |
| Operating income | -$1.31M | -$574.92K | -$181.41K | -$134.84K | -$65.02K | -127.9% |
| Net interest income | -$70.53K | -$70.29K | -$66.30K | -$64.04K | -$62.03K | -0.3% |
| Pre-tax income | -$1.35M | -$430.92K | -$203.60K | -$160.78K | -$112.69K | -212.8% |
| Net income | -$1.35M | -$430.92K | -$203.60K | -$160.78K | -$112.69K | -212.8% |
| Net income to common | -$1.35M | -$430.92K | -$203.60K | -$160.78K | -$112.69K | -212.8% |
| Basic EPS | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| Diluted EPS | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| EBIT | -$1.26M | -$344.58K | -$117.32K | -$77.98K | -$28.84K | -266.6% |
| EBITDA | -$1.15M | -$238.48K | -$17.72K | $21.94K | $67.98K | -382.0% |
| Basic shares | 528.46M | — | 528.09M | 527.36M | 524.08M | — |
| Diluted shares | 528.46M | — | 528.09M | 527.36M | 524.08M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.35M | $1.70M | $1.65M | $1.86M | $1.65M | -20.5% |
| Cash & short-term investments | $1.35M | $1.70M | $1.65M | $1.86M | $1.65M | -20.5% |
| Accounts receivable | $1.27M | $1.42M | $1.97M | $1.73M | $1.69M | -10.3% |
| Inventory | $831.94K | $875.45K | $1.05M | $670.54K | $723.52K | -5.0% |
| Total current assets | $3.92M | $4.63M | $4.98M | $4.57M | $4.56M | -15.3% |
| Property, plant & equipment | $7.21M | $7.13M | $6.76M | $6.80M | $6.84M | +1.2% |
| Goodwill & intangibles | $4.55M | $4.59M | $4.63M | $4.68M | $4.72M | -0.9% |
| Total assets | $17.19M | $17.84M | $17.85M | $17.51M | $17.57M | -3.6% |
| Total current liabilities | $4.45M | $3.97M | $3.69M | $3.11M | $4.63M | +11.9% |
| Current debt | $141.29K | $162.72K | $162.61K | $160.38K | $1.77M | -13.2% |
| Long-term debt | $1.72M | $1.77M | $1.80M | $1.84M | $254.51K | -2.5% |
| Total debt | $4.73M | $4.84M | $4.74M | $4.82M | $4.90M | -2.3% |
| Total liabilities | $14.54M | $14.14M | $13.75M | $13.24M | $13.23M | +2.8% |
| Retained earnings | -$129.58M | -$128.23M | -$127.80M | -$127.59M | -$127.43M | -1.1% |
| Shareholder equity | $2.65M | $3.69M | $4.10M | $4.27M | $4.34M | -28.3% |
| Working capital | -$529.57K | $651.40K | $1.29M | $1.47M | -$69.38K | -181.3% |
| Net tangible assets | -$1.91M | -$900.18K | -$538.31K | -$409.49K | -$376.93K | -111.8% |
| Shares issued | 528.97M | 528.21M | 528.10M | 528.01M | 524.79M | +0.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$1.35M | -$430.92K | -$203.60K | -$160.78K | -$112.69K | -212.8% |
| Depreciation & amortisation | $113.67K | $106.10K | $99.60K | $99.92K | $96.83K | +7.1% |
| Stock-based compensation | $244.06K | $22.46K | $29.57K | -$4.48K | $70.28K | +986.7% |
| Change in working capital | $878.06K | $677.17K | -$44.49K | $362.60K | -$77.63K | +29.7% |
| Operating cash flow | -$72.44K | $410.12K | -$100.40K | $315.56K | -$5.12K | -117.7% |
| Capital expenditure | -$205.18K | -$279.76K | -$64.02K | -$61.49K | -$128.88K | +26.7% |
| Investing cash flow | -$205.18K | -$279.76K | -$64.02K | -$61.49K | -$128.88K | +26.7% |
| Financing cash flow | -$56.84K | -$72.20K | -$28.05K | -$25.01K | -$150.59K | +21.3% |
| Free cash flow | -$277.62K | $130.36K | -$164.42K | $254.07K | -$134.00K | -313.0% |
| End cash position | $2.85M | $3.19M | $3.13M | $3.32M | $3.09M | -10.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Mar 2014 | — | 0.00 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders73.46%
Held by institutions0.00%
Institutions holding1
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.07
+6.06% from price
SMA 20
0.07
+6.87% from price
SMA 50
0.07
+3.55% from price
SMA 100
0.07
-4.63% from price
SMA 200
0.07
-5.08% from price
EMA 12
0.07
+7.44% from price
EMA 26
0.07
+6.09% from price
EMA 50
0.07
+2.94% from price
RSI (14)
53.6
Neutral
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.01
12.24% of price
Realised vol 30D
154.8%
Annualised
Bollinger upper
0.08
20, 2σ
Bollinger lower
0.06
20, 2σ
50 / 200 cross
Death
0.07 vs 0.07
Trend bias
Below 200
-5.08%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.17
More volatile than market
Correlation to SPY
0.17
Largely independent
Realised vol 30D
154.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-54.5%
Peak to trough
Max drawdown 5Y
-75.0%
Peak to trough
ATR 14
0.01
12.24% of price
Beta (reported)
1.25
5Y monthly, from filing
SEC filings
Periodic Financial Reports
10-Q · 2026-08-12
Corporate Changes & Voting Matters
8-K · 2026-07-21
Corporate Changes & Voting Matters
8-K · 2026-07-01
Proxy Statements
DEFA14A · 2026-06-04
Periodic Financial Reports
10-Q · 2026-05-20
Periodic Financial Reports
NT 10-Q · 2026-05-15
Periodic Financial Reports
10-K/A · 2026-04-30
Periodic Financial Reports
10-K · 2026-03-31
Headlines
Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition
PR Newswire · 10d ago
Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio
PR Newswire · 52d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.